Oral contraceptives lower dysglycemia risk in PCOS - Video

Published On 2021-11-08T17:28:00+05:30 | Updated On 8 Nov 2021 5:28 PM IST

Overview

The use of combined oral contraceptive pills (COCP) in women with polycystic ovary syndrome (PCOS) reduces the risk of dysglycemia regardless of their body mass index, a recent study has suggested. The findings, published in the journal Diabetes Care, support "the recommendation that women with PCOS should be screened for type 2 diabetes irrespective of bodyweight category.

Irregular menstrual cycles are related to increased cardiovascular mortality. PCOS is a hormonal disorder characterized by irregular menses and androgen excess. Androgens are known to increase metabolic risk in PCOS women. COCPs are used in PCOS both to reduce the biologically active androgen fraction and for cycle regulation.

For more details, check out the full story on the link below:

Oral Contraceptives Tied To Lower Risk Of Dysglycemia In Women With PCOS: Study

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751